D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Authors:
- Drew WeissmanDWDrew Weissman
- Mohamad-Gabriel AlamehMAMohamad-Gabriel Alameh
- Thushan de SilvaTSThushan de Silva
- Paul ColliniPCPaul Collini
- Hailey HornsbyHHHailey Hornsby
- Rebecca BrownRBRebecca Brown
- Celia C. LaBrancheCLCelia C. LaBranche
- Robert J EdwardsRERobert J Edwards
- Laura SutherlandLSLaura Sutherland
- Sampa SantraSSSampa Santra
- Katayoun MansouriKMKatayoun Mansouri
- Sophie GobeilSGSophie Gobeil
Preprint
Abstract
Summary: The SARS-CoV-2 Spike protein acquired a D614G mutation early in the COVID-19 pandemic that appears to confer on the virus greater infectivity and is now the globally dominant form of the virus. Certain of the current vaccines entering phase 3 trials are based on the original D614 form of Spike with the goal of eliciting protective neutralizing antibodies. To determine whether D614G mediates neutralization-escape that could compromise vaccine efficacy, sera from Spike-immunized mice, nonhuman primates and humans were evaluated for neutralization of pseudoviruses bearing either D614 or G614 Spike on their surface. In all cases, the G614 pseudovirus was moderately more susceptible to neutralization. The G614 pseudovirus also was more susceptible to neutralization by monoclonal antibodies against the receptor binding domain and by convalescent sera from people known to be infected with either the D614 or G614 form of the virus. These results indicate that a gain in infectivity provided by D614G came at the cost of making the virus more vulnerable to neutralizing antibodies, and that the mutation is not expected to be an obstacle for current vaccine development.Keywords
All Related Versions
- Published version: Cell Host & Microbe, 29 (1), 23.
This publication has 40 references indexed in Scilit:
- mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery, 2018
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenProceedings of the National Academy of Sciences, 2017
- Stabilized HIV-1 envelope glycoprotein trimers for vaccine useCurrent Opinion in HIV and AIDS, 2017
- Pre-fusion structure of a human coronavirus spike proteinNature, 2016
- Processing of Structurally Heterogeneous Cryo-EM Data in RELION2016
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesJournal of Controlled Release, 2015
- Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNANanomedicine: Nanotechnology, Biology and Medicine, 2013
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLOS Medicine, 2006
- Very Fast Folding and Association of a Trimerization Domain from Bacteriophage T4 FibritinJournal of Molecular Biology, 2004
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996